DOCSLIB.ORG

Androgen Insensitivity Syndrome: a Survey of Arch Dis Child: First Published As 10.1136/Adc.77.4.305 on 1 October 1997

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Androgen Insensitivity Syndrome: a Survey of Arch Dis Child: First Published As 10.1136/Adc.77.4.305 on 1 October 1997 Archives of Disease in Childhood 1997;77:305–309 305 Androgen insensitivity syndrome: a survey of Arch Dis Child: first published as 10.1136/adc.77.4.305 on 1 October 1997. Downloaded from diagnostic procedures and management in the UK R M Viner, Y Teoh, D M Williams, M N Patterson, I A Hughes Abstract single gene disorder that results in a normal Objective—A two year survey of androgen female phenotype, and typically presents in insensitivity syndrome (AIS) to assess early adult life with primary amenorrhoea, current diagnostic and management although a significant number present with strategies. inguinal hernias in infancy. The significance of Methods—Cases were ascertained by in- the relative rarity of bilateral inguinal hernias in clusion on the British Paediatric Surveil- girls is often not appreciated; it is estimated lance Unit monthly report card for 24 that 1–2% of such infants have complete AIS.4 months. The diagnosis is confirmed in both forms of Results—Fifty one of 139 notifications AIS by a male karyotype and normal testoster- were confirmed as AIS; 29 cases were one production and metabolism, in the pres- complete AIS and 22 cases partial AIS. ence of normal testicular histology, and gener- Seventy six per cent of complete AIS pre- ally the absence of müllerian duct remnants. sented with an inguinal hernia, and half Partial AIS is a clinically heterogeneous dis- the complete AIS patients had an estab- order and presents a more complicated diag- lished family history of the disorder. Pres- nostic problem.25 The degree of androgen entation in the partial AIS group was unresponsiveness is variable, so the aVected through ambiguous or undermasculinised infant presents at birth with undermasculinised genitalia; 59% of partial AIS were raised external genitalia of varying severity. Charac- as male. teristically, there is micropenis with chordee, a Conclusions—The importance of karyo- bifid scrotum, and a perineal urethral opening, typing girls with inguinal hernias is con- and gonads that may or may not be palpable firmed, and further attention should be within the bifid scrotum. The partial AIS phe- given to genetic counselling for families of notype must be diVerentiated from other con- complete AIS patients. A large number of ditions with a 46XY karyoptype, which can cases were misreported as partial AIS, give rise to the same genital abnormality such emphasising the importance of undertak- as defects in testosterone biosynthesis, 5á- reductase deficiency, mixed gonadal dysgen- ing a comprehensive diagnostic evaluation http://adc.bmj.com/ in intersex states. A large percentage of esis, and true hermaphroditism.67 Accurate children with partial AIS were raised as early diagnosis is important and has a profound boys despite severe genital undermascu- bearing on the sex of rearing, genetic counsel- linisation, indicating the current lack of ling, and subsequent management; a trial of validated measures that predict genital androgen treatment in early infancy to assess response to androgen treatment. The the growth of penile erectile tissue may provide management of AIS is discussed and diag- important information on androgen respon- nostic guidelines provided to improve the siveness. There is a lack of knowledge regard- on October 2, 2021 by guest. Protected copyright. ing the criteria used to decide the management Department of diagnostic yield in AIS. Paediatrics, (Arch Dis Child 1997;77:305–309) of infants with partial AIS, particularly with University of respect to sex of rearing. Analysis of the cases Cambridge, Keywords: androgen insensitivity syndrome; inguinal identified through our survey suggests that Addenbrookes hernia; intersex guidelines for clinicians on the appropriate Hospital diagnostic and management strategies for AIS Y Teoh patients, particularly in the case of suspected D M Williams A two year national survey of the androgen partial AIS, would be helpful. M N Patterson insensitivity syndrome (AIS) was undertaken I A Hughes via the British Paediatric Surveillance Unit to University College determine existing diagnostic procedures and Methods London Hospitals, management strategies. A pilot study of SURVEY PROCEDURE Great Ormond Street patients with the partial form of AIS had shown Cases were ascertained by active surveillance Hospital, and that data on gonadal histology, anatomy of the via inclusion on the surveillance unit monthly Middlesex Hospital, internal genitalia, and steroid hormone con- report card for a two year period. Previous London 1 K M Viner centrations were incomplete. AIS defines a studies using multiple ascertainment methods female or ambiguous phenotype in a 46XY have suggested that this reporting procedure Correspondence to: male with testes and normal testosterone alone provides between 60–80% case ascer- Professor I A Hughes, production and metabolism.2 As androgens are tainment rates.8 Cases were defined as an Department of Paediatrics, Addenbrookes Hospital, essential for normal male sexual development infant or child under 16 years of age with a Level 8, Box 116, Hills Road, and fertility, defects in androgen action are 46XY karyotype and with either normal female Cambridge CB2 2QQ. associated with abnormal sexual differentiation external genitalia (defined as complete AIS) or Accepted 10 June 1997 and fertility.3 Complete AIS is a rare X linked abnormal external genitalia that are consistent 306 Viner, Teoh,Williams, Patterson, Hughes with the partial AIS phenotype, that is, esection. Also, as part of a separate study, if a micropenis/clitoromegaly, bifid scrotum, peri- partial AIS patient was undergoing surgery to Arch Dis Child: first published as 10.1136/adc.77.4.305 on 1 October 1997. Downloaded from neoscrotal hypospadias. Clinicians were asked the external genitalia, clinicians were asked to to report any child under their care who satis- provide (after parental consent) a genital skin fied the case definitions, including those newly biopsy specimen as part of the surgical diagnosed in the past month, and those procedure in order to establish fibroblast children diagnosed before the start of the study cultures. Systematic case ascertainment was and who were still 16 years of age, or less, at the confined to the surveillance unit reporting time of the study. scheme. Ethical approval was granted by the Once a case was notified, the referring clini- Cambridge local ethics committee. cian was asked to complete a questionnaire detailing further information about the clinical Results phenotype, family history, imaging studies of Table 1 details notifications during the survey internal genitalia, gonadal histology, results of period. Fifty one of the total 139 notifications endocrine investigations, and management were confirmed as cases of AIS. There was decisions on sex of rearing and hormone treat- insuYcient information to make a diagnosis ment. Determination of diagnosis was made from 37 notifications. The diagnostic criteria from information provided in consultation with for complete AIS and partial AIS were fulfilled referring clinicians. If a case of AIS was in 29 and 22 cases, respectively. confirmed as part of separate studies, referring clinicians were asked to collect blood samples COMPLETE AIS from the index case and family members for All complete AIS patients had normal female DNA extraction, the venesection being coordi- genitalia and were reared as females. Presenta- nated with other investigations requiring ven- tion in complete AIS was predominantly by the discovery of a hernia in an apparently female Table 1 Cases notified to surveillance unit (n=139) infant (76%); other cases were identified on the basis of a family history of the X linked disor- Total notifications No der, or from the determination of a karyotype Exclusions (n=63) for other reasons (table 2). Regardless of the Over age at study 21 Duplicate notifications 5 mode of presentation, inguinal hernia was Unconfirmed cases—no return of questionnaire 37 present in 28 (90%) of complete AIS patients; Cases reported and questionnaire received (n=76) nine (31%) were unilateral, 17 (59%) bilateral. Confirmed complete AIS 29 Confirmed partial AIS 22 Table 3 shows details of gonadal position and Total AIS 51 histology. One or two palpable testes were Other diagnoses: present in approximately 80% of complete AIS Abnormal or dysplastic testes 6 Gonadal dysgenesis 6 patients. Gonadal histology was consistent with Biosynthetic defect (17-hydroxydehydrogenase 1 AIS in all patients in whom histological deficiency) examination of the testes was performed (table Drash syndrome 1 Hypogonadism 1 3). Apart from the report of a ‘vestigial’ uterus Hypopituitarism 1 in one complete AIS patient, female internal http://adc.bmj.com/ Hypospadias 2 Smith-Lemli-Opitz syndrome 2 genitalia were absent in all AIS patients. WAGR syndrome 1 Unknown diagnosis 4 PARTIAL AIS Drash=Wilms’ tumour, male pseudohermaphroditism, and Presentation in partial AIS was through nephropathy. ambiguous or undermasculinised genitalia. In 59% of the partial AIS cases, the sex of rearing Table 2 Mode of presentation in CAIS (n=29) was male. Factors that appeared to aVect sex of rearing in partial AIS were the degree of labio- on October 2, 2021 by guest. Protected copyright. No (%) of cases scrotal fusion, site of urethral opening, whether Bilateral hernia 13 (45) the testes were palpable, and phallus size. All Unilateral hernia 9 (31) Family history 4 (14) infants with unfused labia (n=4) were raised as Amniocentesis 1 (3) female and a further five infants with fused Adoption karyotype 1 (3) labia were also raised as female. All those raised Unknown l (3) as male (n=13) had fused labioscrotal folds. Micropenis was reported in 54% of infants Table 3 Details of gonad position and histology; values are number (%) raised as males, although equal numbers were reported as having normal phallus size. App- Partial AIS roximately 80% of partial AIS patients had one Complete AIS Reared male Reared female or two palpable testes. Infants with palpable (n=29) (n=13) (=9) testes at diagnosis were more likely to be raised Gonad position male, and only one infant without palpable tes- Bilateral intra-abdominal 6 (21) 1 (8) 3 (33) tes was raised as a male (table 3).
Load more

Recommended publications
  • Hyperplasia (Growth Factors
    Adaptations Robbins Basic Pathology Robbins Basic Pathology Robbins Basic Pathology Coagulation Robbins Basic Pathology Robbins Basic Pathology Homeostasis • Maintenance of a steady state Adaptations • Reversible functional and structural responses to physiologic stress and some pathogenic stimuli • New altered “steady state” is achieved Adaptive responses • Hypertrophy • Altered demand (muscle . hyper = above, more activity) . trophe = nourishment, food • Altered stimulation • Hyperplasia (growth factors, . plastein = (v.) to form, to shape; hormones) (n.) growth, development • Altered nutrition • Dysplasia (including gas exchange) . dys = bad or disordered • Metaplasia . meta = change or beyond • Hypoplasia . hypo = below, less • Atrophy, Aplasia, Agenesis . a = without . nourishment, form, begining Robbins Basic Pathology Cell death, the end result of progressive cell injury, is one of the most crucial events in the evolution of disease in any tissue or organ. It results from diverse causes, including ischemia (reduced blood flow), infection, and toxins. Cell death is also a normal and essential process in embryogenesis, the development of organs, and the maintenance of homeostasis. Two principal pathways of cell death, necrosis and apoptosis. Nutrient deprivation triggers an adaptive cellular response called autophagy that may also culminate in cell death. Adaptations • Hypertrophy • Hyperplasia • Atrophy • Metaplasia HYPERTROPHY Hypertrophy refers to an increase in the size of cells, resulting in an increase in the size of the organ No new cells, just larger cells. The increased size of the cells is due to the synthesis of more structural components of the cells usually proteins. Cells capable of division may respond to stress by undergoing both hyperrtophy and hyperplasia Non-dividing cell increased tissue mass is due to hypertrophy.
    [Show full text]
  • Reportable BD Tables Apr2019.Pdf
    April 2019 Georgia Department of Public Health | Division of Health Protection | Maternal and Child Health Epidemiology Unit Reportable Birth Defects with ICD-10-CM Codes Reportable Birth Defects in Georgia with ICD-10-CM Diagnosis Codes Table D.1 Brain Malformations and Neural Tube Defects ICD-10-CM Diagnosis Codes Birth Defect ICD-10-CM 1. Brain Malformations and Neural Tube Defects Q00-Q05, Q07 Anencephaly Q00.0 Craniorachischisis Q00.1 Iniencephaly Q00.2 Frontal encephalocele Q01.0 Nasofrontal encephalocele Q01.1 Occipital encephalocele Q01.2 Encephalocele of other sites Q01.8 Encephalocele, unspecified Q01.9 Microcephaly Q02 Malformations of aqueduct of Sylvius Q03.0 Atresia of foramina of Magendie and Luschka (including Dandy-Walker) Q03.1 Other congenital hydrocephalus (including obstructive hydrocephaly) Q03.8 Congenital hydrocephalus, unspecified Q03.9 Congenital malformations of corpus callosum Q04.0 Arhinencephaly Q04.1 Holoprosencephaly Q04.2 Other reduction deformities of brain Q04.3 Septo-optic dysplasia of brain Q04.4 Congenital cerebral cyst (porencephaly, schizencephaly) Q04.6 Other specified congenital malformations of brain (including ventriculomegaly) Q04.8 Congenital malformation of brain, unspecified Q04.9 Cervical spina bifida with hydrocephalus Q05.0 Thoracic spina bifida with hydrocephalus Q05.1 Lumbar spina bifida with hydrocephalus Q05.2 Sacral spina bifida with hydrocephalus Q05.3 Unspecified spina bifida with hydrocephalus Q05.4 Cervical spina bifida without hydrocephalus Q05.5 Thoracic spina bifida without
    [Show full text]
  • WAGR Syndrome: Clinical Features and Guidelines for Management
    WAGR syndrome: clinical features and guidelines for management Kelly Trout, BSN, RN International WAGR Syndrome Association 2020 Introduction WAGR syndrome is a rare multiple congenital-anomaly syndrome caused by interstitial deletion of the distal portion of chromosome 11p13. Deletion size varies between individuals from 1 million to 26.5 million base pairs, with an average of 11 million base pairs. Variability in size of the genetic deletion is thought to account for the variable phenotype. WAGR is an acronym for the most prominent features: W is for Wilms tumor, A for aniridia, G for genitourinary anomalies, and R for range of developmental delays. Wilms tumor and genital anomalies are caused by deletion of the WT1 tumor-suppressor gene, and aniridia is caused by deletion of the PAX6 ocular development gene. Developmental delays are presumed to be the result of deletion of as yet unidentified genes in the region. Most cases are identified by chromosome studies of children with isolated aniridia and are due to de novo deletions, although a few familial translocations have been reported. Individuals with WAGR syndrome have a high risk for development of Wilms tumor and late-onset renal failure, as well as a variety of additional associated conditions. Diagnosis ● Most cases of WAGR syndrome are identified in infants with isolated aniridia, 30% of whom will be positive for the characteristic deletion (11p13) ● In rare cases, aniridia may not be present. Children with Wilms tumor and genital anomalies may also warrant genetic testing ●
    [Show full text]
  • MECHANISMS in ENDOCRINOLOGY: Novel Genetic Causes of Short Stature
    J M Wit and others Genetics of short stature 174:4 R145–R173 Review MECHANISMS IN ENDOCRINOLOGY Novel genetic causes of short stature 1 1 2 2 Jan M Wit , Wilma Oostdijk , Monique Losekoot , Hermine A van Duyvenvoorde , Correspondence Claudia A L Ruivenkamp2 and Sarina G Kant2 should be addressed to J M Wit Departments of 1Paediatrics and 2Clinical Genetics, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, Email The Netherlands [email protected] Abstract The fast technological development, particularly single nucleotide polymorphism array, array-comparative genomic hybridization, and whole exome sequencing, has led to the discovery of many novel genetic causes of growth failure. In this review we discuss a selection of these, according to a diagnostic classification centred on the epiphyseal growth plate. We successively discuss disorders in hormone signalling, paracrine factors, matrix molecules, intracellular pathways, and fundamental cellular processes, followed by chromosomal aberrations including copy number variants (CNVs) and imprinting disorders associated with short stature. Many novel causes of GH deficiency (GHD) as part of combined pituitary hormone deficiency have been uncovered. The most frequent genetic causes of isolated GHD are GH1 and GHRHR defects, but several novel causes have recently been found, such as GHSR, RNPC3, and IFT172 mutations. Besides well-defined causes of GH insensitivity (GHR, STAT5B, IGFALS, IGF1 defects), disorders of NFkB signalling, STAT3 and IGF2 have recently been discovered. Heterozygous IGF1R defects are a relatively frequent cause of prenatal and postnatal growth retardation. TRHA mutations cause a syndromic form of short stature with elevated T3/T4 ratio. Disorders of signalling of various paracrine factors (FGFs, BMPs, WNTs, PTHrP/IHH, and CNP/NPR2) or genetic defects affecting cartilage extracellular matrix usually cause disproportionate short stature.
    [Show full text]
  • Chapter 1 Cellular Reaction to Injury 3
    Schneider_CH01-001-016.qxd 5/1/08 10:52 AM Page 1 chapter Cellular Reaction 1 to Injury I. ADAPTATION TO ENVIRONMENTAL STRESS A. Hypertrophy 1. Hypertrophy is an increase in the size of an organ or tissue due to an increase in the size of cells. 2. Other characteristics include an increase in protein synthesis and an increase in the size or number of intracellular organelles. 3. A cellular adaptation to increased workload results in hypertrophy, as exemplified by the increase in skeletal muscle mass associated with exercise and the enlargement of the left ventricle in hypertensive heart disease. B. Hyperplasia 1. Hyperplasia is an increase in the size of an organ or tissue caused by an increase in the number of cells. 2. It is exemplified by glandular proliferation in the breast during pregnancy. 3. In some cases, hyperplasia occurs together with hypertrophy. During pregnancy, uterine enlargement is caused by both hypertrophy and hyperplasia of the smooth muscle cells in the uterus. C. Aplasia 1. Aplasia is a failure of cell production. 2. During fetal development, aplasia results in agenesis, or absence of an organ due to failure of production. 3. Later in life, it can be caused by permanent loss of precursor cells in proliferative tissues, such as the bone marrow. D. Hypoplasia 1. Hypoplasia is a decrease in cell production that is less extreme than in aplasia. 2. It is seen in the partial lack of growth and maturation of gonadal structures in Turner syndrome and Klinefelter syndrome. E. Atrophy 1. Atrophy is a decrease in the size of an organ or tissue and results from a decrease in the mass of preexisting cells (Figure 1-1).
    [Show full text]
  • Frasier Syndrome: a Cause of Focal Segmental Glomerulosclerosis in a 46,XX Female
    BRIEF COMMUNICATIONS J Am Soc Nephrol 10: 2215–2218, 1999 Frasier Syndrome: A Cause of Focal Segmental Glomerulosclerosis in a 46,XX Female LAURIE DEMMER,* WILLIAM PRIMACK,*† VALERIE LOIK,‡ ROSALIND BROWN,* NICOLE THERVILLE,§ and KEN MCELREAVEY§ *Department of Pediatrics, University of Massachusetts Memorial Health Care, Worcester, Massachusetts; †Fallon Clinic, Worcester, Massachusetts; ‡Department of Obstetrics & Gynecology, Baystate Medical Center, Springfield, Massachusetts; and §Department of Human Immunogenetics, Institut Pasteur, Paris, France. Abstract. The description of Frasier syndrome until now has diagnosis of Frasier syndrome with 46,XY gonadal dysgenesis, been restricted to XY females with gonadal dysgenesis, pro- whereas her sister has progressive glomerulopathy but a 46,XX gressive glomerulopathy, and a significant risk of gonadoblas- karyotype and normal female development. This indicates that toma. Mutations in the donor splice site in intron 9 of the the proper WT1 isoform ratio is critical for renal and testicular Wilms’ tumor (WT1) gene have been shown to cause Frasier development, but apparently does not affect either ovarian syndrome and are distinct from WT1 exon mutations associ- development or function. It is proposed that the clinical defi- ated with Denys-Drash syndrome. The WT1 gene, which is nition of Frasier syndrome should be broadened to include essential for normal kidney and gonadal development, encodes 46,XX females with normal genital development and focal a zinc finger transcription factor. The intron 9 alternative splice segmental glomerulosclerosis associated with a WT1 intron 9 donor site mutation seen in Frasier syndrome leads to loss of donor splice site mutation. Nephrologists need to consider the three amino acids (1KTS isoform), thus disrupting the normal possibility of this heritable syndrome in evaluation of females ratio of the 1KTS/2KTS isoforms critical for proper gonadal with focal segmental glomerulosclerosis and to consider their and renal development.
    [Show full text]
  • WAGR Syndrome
    International J. of Healthcare and Biomedical Research, Volume: 2, Issue: 4, July 2014, Pages 131-134 Case Report: WAGR Syndrome 1Dr.Prathamesh Patil , 2Dr. C Ashok kumar, 3Dr. Shashank Panwar , 4Dr. R Somdeepak Reddy , 5Dr. Pratik Gogri 1Junior Resident, Pediatrics, Pravara Institute of Medical sciences, Loni, Maharashtra, India 2 Associate Professor of Pediatrics, Pravara Institute of Medical sciences, Loni, Maharashtra, India 3 Junior Resident, Pediatrics, Pravara Institute of Medical sciences, Loni, Maharashtra, India 4 Junior Resident, Pediatrics, Pravara Institute of Medical sciences, Loni, Maharashtra, India 5 Junior Resident, Opthalmology, Pravara Institute of Medical sciences, Loni, Maharashtra, India Corresponding author: Dr. Prathamesh Patil; Email: [email protected] Abstract: WAGR Syndrome is a multiple congenital anomaly syndrome characterized by interstitial deletion of distal portion of chromosome 11p13. It is a gene deletion syndrome. WAGR is an acronym for W- Wilms tumor, A- aniridia, G- genital anomalies and R- mental retardation. Wilms tumor and male genital anomalies are caused by deletion of the WT1 tumor suppressor gene, and aniridia is caused by deletion of PAX6 ocular developmental gene. Mental retardation is thought to be a due of deletion of multiple as yet unidentified genes in the region. The patient needs a multidisciplinary management regimen encompassing the services of an ophthalmologist, radiologist, a pediatrician and pediatric surgeon. Herewith we reported a patient of developmental delay with abdominal distension, child also had aniridia. The child was managed by multidisciplinary approach. Key words: WAGR Syndrome Background: she was found to have aniridia, Wilms tumor and WAGR Syndrome is a multiple congenital anomaly mental retardation. The findings that aniridia is syndrome characterized by interstitial deletion of associated with Wilms tumor made that the findings distal portion of chromosome 11p13.
    [Show full text]
  • CELL INJURY MEDICAL (Lecture 1)
    CELL INJURY MEDICAL (lecture 1) Sufia Husain Assistant Prof & Consultant College of Medicine, KSU, Riyadh. September 2015 Objectives for Cell Injury Chapter (3 lectures) The students should: A. Understand the concept of cells and tissue adaptation to environmental stress including the meaning of hypertrophy, hyperplasia, aplasia, atrophy, hypoplasia and metaplasia with their clinical manifestations. B. Is aware of the concept of hypoxic cell injury and its major causes. C. Understand the definitions and mechanisms of free radical injury. D. Knows the definition of apoptosis, tissue necrosis and its various types with clinical examples. E. Able to differentiate between necrosis and apoptosis. F. Understand the causes of and pathologic changes occurring in fatty change (steatosis), accumulations of exogenous and endogenous pigments (carbon, silica, iron, melanin, bilirubin and lipofuscin). G. Understand the causes of and differences between dystrophic and metastatic calcifications. Lecture 1 outline . Adaptation to environmental stress: hypertrophy, hyperplasia, aplasia, hypoplasia, atrophy, squamous metaplasia, osseous metaplasia and myeloid metaplasia. Hypoxic cell injury and its causes (ischaemia, anaemia, carbon monoxide poisoning, decreased perfusion of tissues by oxygen, carrying blood and poor oxygenation of blood). Free radical injury: definition of free radicals, mechanisms that generate free radicals, mechanisms that degrade free radicals. Reversible and irreversible cell injury ADAPTATION TO ENVIRONMENTAL STRESS Adaptation to environmental stress . Cells are constantly adjusting their structure and function to accommodate changing demands i.e. they adapt within physiological limits. As cells encounter physiologic stresses or pathologic stimuli, they can undergo adaptation. The principal adaptive responses are . hypertrophy, . hyperplasia, . atrophy, . metaplasia. (NOTE: If the adaptive capability is exceeded or if the external stress is harmful, cell injury develops.
    [Show full text]
  • Complete Androgen Insensitivity Syndrome in a Chinese Neonate
    HK J Paediatr (new series) 2004;9:248-252 Complete Androgen Insensitivity Syndrome in a Chinese Neonate MC HO, KL NG Abstract Complete androgen insensitivity syndrome (CAIS) is a rare X-linked disorder with a female external phenotype.1 We report on a Chinese baby with CAIS who presented with bilateral inguinal hernias. The baby has a normal female phenotype at birth. On further evaluation, the karyotype was found to be 46, XY. Endocrine findings were compatible with androgen insensitivity syndrome. Bilateral herniotomy was performed. We would review the literature, offer an overview of the disease, and discuss the outcome with emphasis on the treatment modalities. Key words Complete androgen insensitivity; Male pseudohermaphrodites Introduction investigations which, to the best of our knowledge, has not been reported on the literature.4 Herein we report a case of In 1953, an American gynaecologist JM Morris firstly CAIS in a Chinese neonate in the local region. described a series of individuals with androgen insensitivity syndrome (AIS).2 He reported that these individuals had normal female external genitalia, normal female breast Case Report development, absent or scant axillary and pubic hair, absent internal genital organs and undescended testes. AIS is the The patient was a Chinese baby born at full term by most common condition that results in male under- spontaneous vaginal delivery weighing 2.67 Kg. The masculinisation.3 It is caused by mutations in the androgen antenatal and postnatal course was uneventful. She was the receptor (AR) gene and encompasses a wide spectrum of first child born to the parents. There was no consanguinity male pseudohermaphroditisms.2 In complete androgen nor any significant family history, in particular there was insensitivity syndrome (CAIS), the function of the AR is no abnormal puberty nor infertility on the maternal side.
    [Show full text]
  • Construction of a Natural Panel of 11P11.2 Deletions and Further Delineation of the Critical Region Involved in Potocki–Shaffer Syndrome
    European Journal of Human Genetics (2005) 13, 528–540 & 2005 Nature Publishing Group All rights reserved 1018-4813/05 $30.00 www.nature.com/ejhg ARTICLE Construction of a natural panel of 11p11.2 deletions and further delineation of the critical region involved in Potocki–Shaffer syndrome Keiko Wakui1,12, Giuliana Gregato2,3,12, Blake C Ballif2, Caron D Glotzbach2,4, Kristen A Bailey2,4, Pao-Lin Kuo5, Whui-Chen Sue6, Leslie J Sheffield7, Mira Irons8, Enrique G Gomez9, Jacqueline T Hecht10, Lorraine Potocki1,11 and Lisa G Shaffer*,2,4 1Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX, USA; 2Health Research and Education Center, Washington State University, Spokane, WA, USA; 3Dip. Patologia Umana ed Ereditaria, Sez. Biologia Generale e Genetica Medica, Universita` degli Studi di Pavia, Italy; 4Sacred Heart Medical Center, Spokane, WA, USA; 5Department of Obstetrics and Gynecology, National Cheng-Kung University Medical College, Taiwan; 6Department of Pediatrics, Taipei Municipal Women and Children’s Hospital, Taiwan; 7Genetic Health Services Victoria, Murdoch Children’s Research Institute, Department of Paediatrics, University of Melbourne, Victoria, Australia; 8Division of Genetics, Department of Medicine, Children’s Hospital, Harvard Medical School, Boston, MA, USA; 9Area de Gene´tica, Centro de Desarrollo Infantil y Departamento de Pediatrı´a Hospital Materno Infantil-Hospital Regional Universitario ‘Infanta Cristina’, Badajoz, Spain; 10Department of Pediatrics, University of Texas Medical School at Houston, TX, USA; 11Texas Children’s Hospital, Houston, TX, USA Potocki–Shaffer syndrome (PSS) is a contiguous gene deletion syndrome that results from haploinsufficiency of at least two genes within the short arm of chromosome 11[del(11)(p11.2p12)].
    [Show full text]
  • Wagr Syndrome Information
    CHROMOSOME DISORDER OUTREACH WAGR SYNDROME INFORMATION WAGR Syndrome WAGR is an acronym from the first letters of the mainmanifestations of this condition: Wilms tumor (W), aniridia (A), genital abnormalities (G) and retardation (R). The association of these defects has been known since the 1960s, but the chromosomal etiology of this syndrome was first reported in 1978-1979 (1). The chromosomal segment 11p13 includes two nearby genes – PAX6 and WT1, and the deletion of these genes determines the main manifestations of the syndrome. WAGR is a relatively common condition; at least 200 patients have been reported so far. The first manifestation of the syndrome is aniridia (absence of the iris). This defect may be revealed upon the examination of a newborn baby. Aniridia may be complete or partial. Glaucoma and cataracts often develop as a consequence of aniridia. Aniridia itself is caused by a mutation in the PAX6 gene and in many families this defect is inherited in an autosomal dominant manner. If however aniridia in a newborn baby is sporadic it is a strong indication for a cytogenetic examination to exclude deletion 11p13 underlying this eye defect. At least one third of patients with sporadic aniridia may have 11p13 deletion and (as a result) other manifestations of WAGR syndrome. Molecular cytogenetic examinations show that in rare instances aniridia may be caused by deletions of the regulatory elements nearby the PAX6 gene, but the gene itself may be unaffected (2). Genital abnormalities vary from one patient to another. Most boys reveal cryptorchidism. Hypospadias or ambiguous genitalia are relatively uncommon. Girls usually do not reveal genital abnormalities, although there are reports of streaked ovaries, hypoplastic or bicornuate (a type of congenital uterine malformation or müllerian duct anomalies in which the uterus page 1 appears to be heart shaped) uterus, etc.
    [Show full text]
  • Appendix 3.1 Birth Defects Descriptions for NBDPN Core, Recommended, and Extended Conditions Updated March 2017
    Appendix 3.1 Birth Defects Descriptions for NBDPN Core, Recommended, and Extended Conditions Updated March 2017 Participating members of the Birth Defects Definitions Group: Lorenzo Botto (UT) John Carey (UT) Cynthia Cassell (CDC) Tiffany Colarusso (CDC) Janet Cragan (CDC) Marcia Feldkamp (UT) Jamie Frias (CDC) Angela Lin (MA) Cara Mai (CDC) Richard Olney (CDC) Carol Stanton (CO) Csaba Siffel (GA) Table of Contents LIST OF BIRTH DEFECTS ................................................................................................................................................. I DETAILED DESCRIPTIONS OF BIRTH DEFECTS ...................................................................................................... 1 FORMAT FOR BIRTH DEFECT DESCRIPTIONS ................................................................................................................................. 1 CENTRAL NERVOUS SYSTEM ....................................................................................................................................... 2 ANENCEPHALY ........................................................................................................................................................................ 2 ENCEPHALOCELE ..................................................................................................................................................................... 3 HOLOPROSENCEPHALY.............................................................................................................................................................
    [Show full text]